These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2277411)

  • 21. Intracoronary acetylcholine-induced prolongation of the QT interval and Torsade des Pointes in long QT interval syndrome.
    Aizawa Y; Matsubara T; Higuchi K; Washizuka T; Tamura Y; Uchiyama H; Igarashi Y; Shibata A
    Jpn Heart J; 1994 Sep; 35(5):683-8. PubMed ID: 7830332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Classification and treatment of torsades de pointes (TdP): a report of 11 cases].
    Mei KZ; Sun AH; Li BJ
    Zhonghua Nei Ke Za Zhi; 1993 Jan; 32(1):28-30. PubMed ID: 8404313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G
    Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome.
    Gallacher DJ; Van de Water A; van der Linde H; Hermans AN; Lu HR; Towart R; Volders PG
    Cardiovasc Res; 2007 Nov; 76(2):247-56. PubMed ID: 17669388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe.
    D'Alonzo AJ; Zhu JL; Darbenzio RB
    Eur J Pharmacol; 1999 Mar; 369(1):57-64. PubMed ID: 10204682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fragmented endocardial signals and early afterdepolarizations during torsades de pointes tachycardia.
    Li GL; Saguner AM; Fontaine GH; Frank R
    Cardiol J; 2020; 27(1):54-61. PubMed ID: 30009377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monophasic action potentials in patients with torsades de pointes.
    Miwa S; Inoue T; Yokoyama M
    Jpn Circ J; 1994 Apr; 58(4):248-58. PubMed ID: 8051783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome. Investigator Group for K-Channel Openers and Arrhythmias.
    Aizawa Y; Uchiyama H; Yamaura M; Nakayama T; Arita M
    J Electrocardiol; 1998 Apr; 31(2):117-23. PubMed ID: 9588657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug therapy for torsade de pointes.
    Banai S; Tzivoni D
    J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
    Shimizu W; Antzelevitch C
    Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias.
    Verduyn SC; Vos MA; Leunissen HD; van Opstal JM; Wellens HJ
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):212-22. PubMed ID: 10028928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicorandil, a potassium channel opener, abolished torsades de pointes in a patient with complete atrioventricular block.
    Watanabe O; Okumura T; Takeda H; Nakamura W; Segawa K; Ito H; Yoshimoto N
    Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):686-8. PubMed ID: 10234727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 1997 Sep; 96(6):2038-47. PubMed ID: 9323097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases.
    Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T
    J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
    Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K
    J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification and mechanism of Torsade de Pointes initiation in patients with congenital long QT syndrome.
    Noda T; Shimizu W; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S
    Eur Heart J; 2004 Dec; 25(23):2149-54. PubMed ID: 15571831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes.
    Madias C; Fitzgibbons TP; Alsheikh-Ali AA; Bouchard JL; Kalsmith B; Garlitski AC; Tighe DA; Estes NA; Aurigemma GP; Link MS
    Heart Rhythm; 2011 Apr; 8(4):555-61. PubMed ID: 21146632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.